{'fraction_non_alphanumeric': 0.023835319609967497, 'fraction_numerical': 0.009750812567713976, 'mean_word_length': 5.416666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Aripiprazole is effective in the treatment of Tourette's disorder.

Tourette's disorder is a chronic neuropsychiatric disorder including multiple involuntary motor and vocal tics. We report the clinical case of a 23-yr-old girl with Tourette's disorder and a successful treatment of this condition with aripiprazole, a new antipsychotic drug with dopamine-2 (D2) receptor antagonism under hyperdopaminergic conditions and with D2 receptor agonism under hypodopaminergic conditions. After 3 wk treatment with 15 mg/d aripiprazole, both motor and vocal tics had almost completely disappeared. The treatment was well tolerated by the patient. The only reported side-effect was insomnia during the first 3 wk of treatment. This encouraging case report should justify long-term placebo-controlled trials to further establish the treatment of tics with aripiprazole in this life-long disorder with severe functional consequences.